Detalles de la búsqueda
1.
Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study.
Diabetes Obes Metab;
25(2): 435-443, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36199242
2.
Lifestyle changes and kidney function: A 10-year follow-up study in patients with manifest cardiovascular disease.
Eur J Clin Invest;
52(9): e13814, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579056
3.
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).
Eur J Prev Cardiol;
30(1): 61-69, 2023 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208182
4.
Estimated Life-Years Gained Free of New or Recurrent Major Cardiovascular Events With the Addition of Semaglutide to Standard of Care in People With Type 2 Diabetes and High Cardiovascular Risk.
Diabetes Care;
45(5): 1211-1218, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35263432
5.
Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes: 10-Year and Lifetime Risk Prediction Models.
Clin J Am Soc Nephrol;
17(12): 1783-1791, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36332974
6.
End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study.
J Nephrol;
34(5): 1511-1520, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33713332
7.
Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901-907.
Diabetes Care;
44(6): e139, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34016608
8.
[HIV may be cured]. / Hiv kan måske kureres.
Ugeskr Laeger;
177(17)2015 Apr 20.
Artículo
en Danés
| MEDLINE | ID: mdl-25922162
Resultados
1 -
8
de 8
1
Próxima >
>>